Digitisation | November 11, 2025
Nitinotes secures CE mark for automated suturing platform ‘EndoZip’
Enabling a new era in minimally invasive obesity treatment across Europe
Enabling a new era in minimally invasive obesity treatment across Europe
The expanded mbDNA portfolio delivers enhanced stability, reduced immunogenicity, and broad compatibility with gene insertion and expression technologies
The offering is expected to close on November 10, 2025, subject to customary closing conditions
Poviztra is a second brand of Wegovy
The device delivers clear, high-quality images to support accurate diagnoses across a broad range of patient groups
During the quarter, Zydus Wellness completed the acquisition of Comfort Click Limited and its subsidiaries
The study demonstrated strong clinical outcomes, with 94.8 per cent of subjects remaining free from major target limb amputation at one year
Teva reported third quarter revenues of $4.5 billion, an increase of 3 per cent year-over-year.
Subscribe To Our Newsletter & Stay Updated
